Core Viewpoint - Shenzhen Kaili Biomedical Technology Co., Ltd. is undergoing a review of its compliance with various regulations regarding its stock incentive plan and related disclosures [1][3][6]. Compliance Requirements - The financial report for the most recent accounting year did not receive a negative opinion or inability to express an opinion from the registered accountant [3]. - There have been no instances in the last 36 months where profit distribution was not conducted according to laws, regulations, or company articles [3]. - The stock incentive plan must not exceed 20% of the company's total share capital [3][4]. Incentive Object Compliance - The incentive plan includes individuals holding 5% or more of the company's shares, with justifications for their inclusion [3][4]. - No major violations leading to administrative penalties from the China Securities Regulatory Commission (CSRC) have occurred in the last 12 months [3][4]. - The plan must disclose the names, positions, and number of rights granted to directors and senior management [4][5]. Disclosure Completeness - The plan must detail compliance with the Stock Incentive Management Measures, including the purpose and scope of the incentive [4][5]. - The total number of rights to be granted and their percentage of the company's total share capital must be specified [4][5]. - The plan must include the effective period, authorization date, and conditions for exercising rights [4][5]. Performance Assessment - The performance assessment indicators for exercising rights must be disclosed, ensuring they are objective and reasonable [4][5]. - The plan must clarify the rights and obligations of both the company and the incentive objects, including dispute resolution mechanisms [5][6]. Legal and Procedural Compliance - The company must ensure that the stock incentive plan does not harm the interests of the company and all shareholders [5][6]. - Legal opinions from law firms must be obtained to confirm compliance with relevant regulations [5][6].
开立医疗: 2025年限制性股票与股票期权激励计划自查表